Our findings reveal that luminal myofibroblasts develop from SMCs and their formation (in multiple forms of systemic vasculitis) is driven by activation of the mechanistic target of rapamycin (mTOR) signalling pathway. Here, MTOR is linked to necrotizing vasculitis.